Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2024BiomedicinesOpen Access

Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPaul SacksteinAWAlexis K. WilliamsRZRachel Zemel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sackstein et al. (2024) studied this question.

synapsesocial.com/papers/68e6d2d1b6db6435876500c8https://doi.org/10.3390/biomedicines12050975
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors2013 · 38 citations
  2. 2<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome2021 · 173 citations
  3. 3Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial2015 · 173 citations
  4. 4Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML2024 · 48 citations
  5. 5CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes2018 · 149 citations